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Arterial ketone body ratio (AKBR) was measured se-
quentially in 84 liver transplantations (OLTx). These 
transplantation procedures were classified into 3 groups 
witll respect to graft survival and patient condition at 
the end of the first month (Group A, the grafts survived 
longer than 1 month with satisfactory patient condition; 
Group B, the grafts survived longer than 1 month but 
the patients were ICU-bound; Group C, the grafts were 
lost and the patients died or underwent re-OL Tx). In 
Group A, the AKBR was elevated to above 1.0 by the 
second postoperative day. In Group B, the AKBR was 
elevated to above 0.7 but stayed below 1.0 during this 
period. In Group C, the AKBR remained below 0.7 
longer than 2 days after operation. Although conven-
tional liver function tests showed significant increases 
in Groups Band C as compared with Group A, they were 
less specific in predicting ultimate graft survival. 
Sel-eraJ parameters have been proposed for the prediction of 
liver graft failure, such as the levels of hepatic enzymes, serum 
bilirubin, plasma amino acids, and biopsy findings (J, 2), but 
none can forecast graft recovery until the patient's condition 
becomes critical. As a step toward this objective, an interinsti· 
tutional study was undertaken between Kyoto University and 
the University of Pittsburgh. The Kyoto team has quantified 
derangements of hepatic energy metabolism after cirrhotic liver 
resection, liver transplantation, and other disease states (3-5). 
The redox potential (reduction-oxidation potential) of hepatic 
mitochondria is one of the fundamental regulatory factors of 
the liver metabolism. and can be assessed by measuring the 
ketone body ratio in the arterial blood (AKBR)* of patients 
(3). The AKBR is closely correlated with the energy charge 
level of the liver in jaundice, massive hemorrhage, experimental 
liver transplantation, and after hepatic resection (6-8). 
After liver transplantation, patients with well-functioning 
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grafts usually recover from the stress of the operation quickly 
and uneventfully, and can be discharged within one or 2 days 
from the intensive care unit (leU). In contrast, there is extreme 
morbidity and mortality in patients whose new livers do not 
resume function promptly, whose grafts fail secondarily because 
of rejection or technical accidents, and whose grafts are sec. 
ondarily damaged after renal or cardiopulmonary complications 
(9). Accurate prediction of the fate of these hepatic grafts is an 
important objective. 
The Hannover liver group proposed the metabolic assessment 
of transplanted liver allografts with AKBR as a parameter (10, 
11). They showed that an AKBR below 0.7 at 24 hr after organ 
recirculation was an early predictor of graft failure, but did not 
provide information beyond the first day. In the present study, 
the redox potential of the liver allografts was monitored with 
AKBR during the operation and daily until the patient was 
discharged from the ICU, died, or underwent retransplantation. 
A close relationship between the ultimate graft function and 
the changes in the AKBR within 2 postoperative days could be 
documented. This information should be helpful in making 
early decisions in future cases about the need for retransplan-
tation. 
MATERIALS AND METHODS 
Between Septembef 9, 1989 and Decembef 13, 1989,81 adult patients 
were studied after 87 orthotopic liver transplantations (OL Tx). Two 
patients who died of strokes in the immediate postoperative period and 
one who died of cytomegalovirus pneumonia on the 29th postoperative 
day were excluded from the analysis_ Thia left 84 OL TJ in 78 patients 
for analysis. There were 42 males and 36 females, with ages ranging 
between 16 and 66 years (mean±SEM: 4S.7±L4l. Their diverse ofiginsl 
diseases are summarized in Table 1. The degree of iIlnesa of each 
patient was defined prospectively by the criteria for urgency used by 
the 6-tier United Network for O",an Sharing (UN OS) distribution 
system (12). 
Seven of ~ 78 patients had a diagnosis of diabetes mellitus before 
operation_ Four were insulin·dependent and another 3 were on oral 
hypoglycemic qents for control of blood sugar. An additional 5 patients 
also required insulin during the immediate postoperative period. and 
in the data ltnltification these were classified as diabetic. 
TrtJTl8plDnl procedures_ All donor procurements were with in situ 
infusion techniques (13). The liven were preserved for 12.9±O.68 (mean 
± SEM) br with Univenity of Wisconsin solution. HLA typing and 
cytotoxic antibody croumatch was performed but did not influence 
case selection .mce the results were not known until later. The anhe-
patic phase _ defined as the interval between the interruption of the 
recipient'. hepatic circulation and the reatoration of portal or arterial 
circulation to the graft. Throughout the operation, inciudiJ\( the an· 
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TABLE 1. Indications (or orthotopic li\'er transplantation 
SumberoC 
Diagnosia Sumberof rrafU that 
cr-fta used failed within 
the first month 
Cirrhosis, idiopathic 26 4 
Cirrhosia, hepatitis 12 2 
Cirrhosis, autoimmune 4 1 
Primary biliary cirrhosia 7 1 
Secondary biliary cirrhoaia 2 0 
Sclerosing cholangitia 7 0 
Carolia disease 1 0 
Alagille's syndrome 0 
Biliary atresia 1 0 
Graft failure' Rejection 6 2 
Hepatitis 3 0 
Hepatic artery stenosis 2 0 
Undetermined 4 3 
Othen Fulminant hepatitis 1 0 
Malignant tumor 3 0 
Budd·Chiari syndrome 2 0 
Wilson's disease 0 
Hemochromatosis 0 
• Six of these transplantations were after primary transplantation 
that failed during the time of study. The other 9 were for graft failure 
foUowing transplantation in an earlier year in patients whose primary 
course was not studied. 
hepatic phase, serum lactate, blood glucose. and blood gases were 
measured at frequent intervals. 
ImmuTI08uppression and rejection. Sixty-eight of the 8-l crafts (in· 
cluding retransplantations) were under treatment with FK506. to which 
a rapidly tapering course of prednisone was added, usually starting 
with 200 mg on the fmt day, and ending with 20 mg on the sixth day. 
The other 16 transplantations were done with limilar management but 
with cyc1osporine instead of FK506, and azathioprine in addition if 
there was a peripheral WBC >4000/mm'. In 2 patients. a course of 
OKT3 was started within the first 7 days because of suspicion of 
accelerated rejection, and in 9 patients whose grafts failed to function 
promptly one or more treatments with hemodialysis or continuous 
venovenous hemofiltration were given in the hope that antibodies or 
some other undetected harmful substance could be remo\-ed, 
The AKBR was measured within 40 min by the enzymatic method 
using a Ketorex kit (Sanwa Chemical Company. LTD. Nagoya, Japan) 
and a KETO·340 semiautomatic spectrophotometer IIhara·denshi 
Company, LTD, Kasugai, Japan) (14, 15). Four milliliurs of arterial 
blood was withdrawn before the portal vein wu undamped, at 6, 12, 
and 24 hr after organ reperfusion, and once a day thereafter until the 
patient was discharged from the ICU, or died. No hypociycemia was 
encountered at the time of the AKBR measurement. The management 
of the patients in the ICU was performed independently of the AKBR 
measurement. 
Stotistical analyses. Statistical analyses were baaed on analysis of 
variance and the t taL A P value less than 0.05 was regarded as 
significant. Values are expreased ss the mean ± SEM. Receiver oper-
atinl characteristic curve analyses were applied to comparison of 
various clinical parametel1l and AKBR. 
RESULTS 
Of the 78 patients, 70 (89.7%) are alive. Survival was mark-
edly influenced by the original diagnosis, with the poorest 
results being in patients with cirrhosis and in those undergoing 
retranspiantation after the first graft had been lost (or unex-
plained reasons (Table 1). These latter patients have been 
called "liver-eaters." The following analyses are of graft sur-
vival. 
Overall graft survil,,'Cll. In 66 (78.6%) of the 84 transplanta-
tions, the patients were discharged from the ICU in satisfactory 
condition within one month. These procedures were designated 
group A (successful graft). After 5 (6.0%) transplantations, the 
patienta were still on the ICU at the end of the first month. 
Their procedures were consigned to group B (compromised 
graft). Another 13 (15.4%) operations constituted group C 
(failed graft). Five of these recipients underwent retransplan-
tation. 
Table 2 shows the clinical features in the 5 compromised 
graft cases of group B. Patient 1 was undergoing retransplan' 
tation because of primary graft nonfunction 2 days after the 
first OLTx. All of the patients were classified as classes 4-6 by 
the United Network for Organ Sharing. Class 5 patients are 
ICU·bound and class 6 patients are life support-dependent. All 
5 required hemodialysis and/or mechanical respiratory assist 
postoperatively and all but one (case 2) had progressive in· 
creases in bilirubin levels. Patient 3 survived the study period 
but ultimately underwent retransplantation on the 46th post· 
operative day. 
In group C, graft death occurred, with a mean interval of 
11.4±2.9 days (Table 3). Specimens of eleven grafts were ex· 
amined by a pathologist during either the re-OL Tx or at au-
topsy. In the other cases in which an autopsy was denied, the 
final diagnosis of the graft was made based on the clinical 
events, premortem hepatic biopsies, and infectious disease data. 
The majority of the failed grafts had necrosis or severe ischemic 
injury. Five were lost from death or retransplantation after 1-
4 days. Ischemic injury "."jth the supervention of sepsis led more 
slowly to the same result in the other 7 after 12 days. Sepsis 
was thought to have caused delayed hepatic failure in 4 of these 
patients. Humoral or cellular rejection was the primary diag-
nosis in patients who became septic secondarily. 
Graft viability and AKBR. The AKBR was significantly sup-
pressed in groups B and C as compared with group A, suggesting 
a close correlation between the redox state of the mitochondria 
of the transplanted graft in the early postoperative days and 
graft survival (P<O.OI) (Fig. 1). Because the ATP synthesizing 
ability of the liver mitochondria is closely related to the insulin 
level (16), the changes in the AKBR after OL Tx were measured 
in diabetic and nondiabetic patients. In 12 diabetic patients in 
group A the AKBR was significantly suppressed as compared 
with that in the 54 nondiabetic patients up to the third post· 
operative day (Fig. 2). Afterv.·ards the AKBR increased as 
insulin need decreased or with stabilization of insulin require· 
ments. 
Among the 54 nondiabetic cases in group A, 24 were success-
fully discharged from the ICU within 2 days. The AKBRs in 
the morning of the day of discharge from the leu are shown 
in Figure 3. All were ahove 1.05. 
AKBR in nondiabetics. Because of the confounding factor of 
insulin therapy, a separate analysis was performed of AKBR 
after culling 12 diabetic patients in group A and one diabetic 
patient in group C. For this analysis, the following stratification 
was used: state I, AKBRi:l.O; state II, 0.7-1.0; state III, 
AKBR<0.7. 
Group A: In 52 (96.3%) of 54 nondiabetic patients, the AKBR 
was elevated in state 1 by 2 days, and in 11 of these state I had 
already been reached within 24 hr. In the 2 exceptional cases 
(3.7%) the ratio was restored to state I by the 5th postoperative 
day. 
Group B: In all 5 cases, the AKBR remained in state II 
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TABLE 2. Clinical profiles of 5 cases witb compromised grafts (group B) 
No. (ace/lex) 
1 (63fF) PNC-C' 
2 (37fF) PNC-E 
3 (35fF) PNC-C 
.( (321M) WillOIl', disease 
5 (56IF) PNC-B 
Preoperative cia .. • 
Clau6 
Re-OL Tx 2 days after 
the lit OLTx, 
renal failure 
Class 4 
Encephalopathy 
Clau4 
Encepbalopathy 
Class 5 
Respiratory failure, 
encephalopathy 
Class 5 
Pulmonary edema 
encephalopathy 
Poatoperative coune 
CsseERml~F 
Cardioversion (5 POD) 
BioplY (17 POD): mild acute rejection 
Bilirubin' 
Mechanical ventilation 
(OP_10POD) 
BioplY (10 POD): necrosis 
Biopsy (27 POD): moderate rejection 
Renal failure, hemodialysis (5 POD--+) 
Respiratory failure 
Bilirubin,' Re-OLTx (46 POD) 
Renal failure, hemodialysis (2 POD--+) 
Mechanical ventilation (OP--) 
Bilirubin' 
Mechanical ventilation (OP .... 5 POD, 7 POD--+) 
Renal failure (3 ml~FI 
Laparotomy for bleeding (13 POD) 
Bilirubin' 
• The criteria for urgency using for the UNOS distribution Iystem: Class 4, hospitAl-bound, not in intensive care unit (lCU); Clus 5, ICU-
bound, not ventilator-dependent; Class 6, in ICU, on ventilator, and often unconscious. 
• PNC: postnecrotic cirrhosis: PSC-C: cryptogenic; PNC-E: ethanol; PNC-B: hepatitis B; CVVH: continuous venovenous hemofiltration. 
'Total bilirubin level increased progressively more than 10 mg/d! or the pre-OL Tx level. 
TABLE 3. Clinical profiles of 13 failed grafts 
Diqnoaia Graft No. Survival Outcome AKBRatate 
Graft necrosis (PNF") 
Rejection (plus sepsis) 
Ischemia (plus rejection) 
IIc:hemia (plus sepsis) 
3 
2 
1 
2,3, .( ReOL Tx, ReaL Tx, ReOL Tx 
Died, died 
m.. m, II 
aD 16,30 
7 ReOLTx 
Sepsil (plus secondary liver failure) 
Cardiopulmonary failure (plus secondary 
12 
17,21,22,20 
2 
Died 
Died, died, died, died 
ReOLTx 
I i-D) 
m 
a D_ II, II 
D 
liver congestion) 
Intraperitoneal bleeding 
2 
... 
II 
II: 
• Primary nonfunctioning graft. 
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T illle after Transplantation 
FIGURE 1. Changes in the AKBR immediately after OL Tx in rela-
tion to graft outcome. Values are presented 81 means ± SEM. (0) and 
(00): P<O.05 and P<O.Ol, respectively. (0) successful graft (group A); 
(6) compromised graft (group B); (e) failed graft (group C). (AHP) 
anhepatic period. 
Died m 
during the first 2 days. Figure 4 shows the eventual changes in 
the AKBR of these 5 patients. Their AKBR fluctuated with a 
relatively high amplitude during their stay in the ICU, but 
never maintained normal levels (state I). 
Group C: In 7 of 12 cases the AKBR remained in state II for 
the first two postoperative days and gradually decreased to 
state III (Fig. 5). Five of the 7 cases died and two underwent 
re-OL Tx. In one patient, the AKBR was in state I after one 
day but declined to state II (0.71) by the second postoperative 
day (Fig. 5). This patient underwent re-OL Tx .-ith the diag-
nosis of accelerated acute rejection made from surgical speci-
men. In another 4 patients, the AKBR remained in state III 
without fluctuation (Fig. 6). All patients were in critical con-
dition. Two of the 4 patients underwent re-OLTx and the other 
2 patients died 
Figure 7 shows a schematic representation of the above 
resulta in nondiabetic patients, correlated with the outcome of 
OLTx. When the AKBR was restored to above 1.0 within 2 
days after OL Tx, all grafts resumed satisfactory initial func-
tion_ When the AKBR was suppressed below 0.7 'state III) for 
longer than 24 hr after OLTx, no grafts survived. When the 
AKBR was between 0.7 and 1.0 (state II) for two days after 
~--------
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FIGURE 2. Comparison of the changes in the AKBR immediately 
afWr OL Tx between diabetic (OM) and nondiabetic (non·DM) patients 
with successful grafts. Values are presented as means ± SEM. (0) non-
DM; (e) DM. (.) and ( •• ): P<O.05 and P<O.Ol. respectively. (AHP) 
anhepatic period. 
OLTx. 50% of the grafts failed and 36% of the grafts were 
compromised (i.e., succeeded. although with a prolonged recov-
ery). 
In 2 exceptional patients in group A the AKBR decreased 
rapidly after it first rose to state I on the first day. The cause 
of the rapid decrease could have been acute rejection, an unrec-
ognized technical error, or inappropriate postoperative care. 
Figure 8 shows how acute rejection can effect AKBR at a later 
time. A 51-year-old woman suffering from hemocromatosis had 
an AKBR of 1.5 on the first and second postoperative days but 
it decreased below 1.0 as the bilirubin began to rise on the third 
postoperative day. Therapy with cyclosporine was replaced with 
FK506 5 days after transplantation. The AKBR increased to 
1.5 of normal levels, concomitant with normalization of the 
bilirubin level. 
Various clinical parameters and AKBR. Table 4 shows the 
changes in the levels of lactate, total bilirubin. GOT. GPT. and 
PT in each group. The levels of total bilirubin on the first and 
second postoperative days were significantly increased in 
groups Band C as compared with those in group A (P<O.OO5). 
The levels of GOT and GPT on the first and second postoper-
ative days were significantly increased in group C as compared 
with those in groups A and B. The levels of lactate at the end 
of operation and PT on the rll'St operative day were significantly 
increased in group C as compared with those in group A. These 
conventional liver function tests were shown to be inaccurate 
in discriminating between group A and group C, however, when 
compared with AKBR by receiver operating characteristic 
curve analysis (Figs. 9 and 10). 
AKBR in primary and retranspliJnt cases. Of the 84 grafts 
whose function was studied here, 69 were primary and the other 
15 were retransplantations. In 6 of 15 retransplantations. both 
the primary and secondary graftings were followed with AKBR 
testing. In the other 9 cases, the primary grafting had been 
done before this study, and only the second liver could be 
studied. The first grafts were lost later for a variety of reasons. 
and after retransplantation the AKBR had decreased more 
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FIGURE 3. The AKBRs of 24 patients at discharge from the ICU by 
the second postoperative day. 
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FIGURE 4. Change. in the AKBR after OLTx of the 5 case. with 
compromised grafts. (AHP) anhepatic period. 
than with primary grafting (Fig. 11). This observation empha-
sized the greater risk of graft failure born by patients undergo-
ing retransplantation after the failure of a first graft_ 
DISCUSSION 
It is documented that a reduced redox state of hepatic mito-
chondria indicating the accumulated intramitochondrial 
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F'lGURE 6. Changes in the AKBR after OL Tx of the 4 cases with 
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NADH, inhibits the activity of citrate synthase. which controls 
the turnover rate of the Krebs cycle, and the activity of pyruvate 
dehydrogenase. which controls the reaction from pyruvate to 
acetyl CoA. These result in a fall in the ATP-synthesizing 
ability of the liver mitochondria. With the depletion of ATP, 
many biological reactions cease in the hepatocytes, and biolog-
ical membranes start to malfunction. There is considerable 
evidence to show that the AKBR is correlated closely with 
hepatic functions, not only in the case of primary hepatic 
disease but also in hemorrhagic shock, hypoxia, hemodilution, 
and multiple organ failure. As a result, the redox theory is 
gradually receiving wider acceptance among investigators, and 
the assessment of hepatic function according to AKBR has 
begun to be adopted in the medical field. 
Because it has been suggested that the mitochondrial func-
tion is a powerful predictor of the outcome of hepatic surgery 
(3, 4), it was natural to apply the AKBR testing in liver 
transplantation. In the present study a close correlation of the 
redox state of the graft mitochondria with graft survival was 
clearly demonstrated. During the anhepatic state, a rapid de-
crease in the AKBR occurred that was promptly returned 
toward normal by a well-functioning graft. This restoration did 
not occur if the liver had been damaged by events in the donor 
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FIGURE 7. Relationship between the increase pattern of the AKBR 
by the second postoperative day and graft outcome. (e) 50% includes 5 
compromised cases that succeeded., although with prolonged recovery. 
• 0 
mg/dl a: 
III 
:0£ 
« 
4 2.0 
. 
y_-~ I 
c: 3 1.5 \.. ! 
-€ •• , 
... \ \ I 
~ "",' ~ \ -
.. b---'O.. 
"- ,,' ......... 
........... ,1 
al 2 \.0 
1 0.5 
o l~~--~~~~~~~~~--i-~~ 
1 2 3 4 5 6 7 8 9 10 11 12 
Days after T r ansplantalloll 
FIGURE 8. A typical case in ... hich the recovery of the AKBR was 
obtained by FK506. (0) AKBR; ee) bilirubin. 
death, poor procurement or preservation, or performance of a 
flawed recipient operation. b~Den with a good liver, the AKBR 
could secondarily fail as early as 2 days after an initial increase. 
This may be due to accelerated rejection or other unidentified 
recipient factors. 
The AKBR test is discriminating of liver quality, but it does 
not determine the etiology of the dysfunction. Taki et aI. (10, 
11) reported that the cut-off below which recovery could not 
be expected after liver transplantation was 0.7 when the deter-
mination was made after 24 hr_ After liver transplantation, the 
restoration and maintenance of a high AKBR depends upon 
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TABLE 4. Comparison of various parameters among groups A, a, and C 
T·BIL (mg/d1) GOT (/U/ml) GPT (IU/mll PT (oecond) Lactate' 
(mmol/L) 1 POD 2 POD 1 POD 2 POD 1 POD 2POD 1 POD 2 POD 
GrouP A S.6±O.4 S.2±0.4 3.7±O.4 906.6±96.4 S98.9±93.1 771.0±88.5 823.9±133.6 16.4±O.5 16.4±1.9 
GrouP B S.0±2.3 12.S±2.t 10.3±2.S· 956.8±226.8 458.2± 110.6 S47.6±1l0.3 6&5.6± 17S.6 16.9±O.8 IS.3±l.4 
. Group C 9.2±2.0' 9.8± 1.6" 1l.2± 1.9" 2816.1±644.9'" 3107.H89U),," 2139.0±S30.9'" O4UMKS±U1PK~ O1KM±1K~ 18.4±1.2 
~eU at the end of the operation. 
-Group A versus group a, P < 0.005. 
'Group A versus group C, P < 0.01. 
I GroUP A versus group C, P < O.ooS. 
'Group a versus group C, P < 0.05. 
'Group B versus C, P < O.ooS. 
100'"' 
spec, I 'City 0,", 
0" 
l~ 
0" 
FIGURE 9. Receiver operating characteristic curve for the analysis 
of accuracy in discriminating between the successful U1d the failed 
graft groups. (upper left) Comparison between GOT aDd GPT with 
AKBR on the 1st postoperative day; (upper right) Comparison between 
several factors: (1) recipient condition, (2) the viability of the 
donor liver, (3) the degree of intraoperative stress caused by 
anesthesia, transfusions, and transplantation techniques, (4) 
proper general postoperative care, and (5) harmful immune 
events including rejection. If the AKBR decreases, the cause is 
probably the failure to adequately meet one or more of these 
requirements. Which one(s) may be difficult to identify, but a 
signal can be obtained within 24 to 48 hr that retransplantation 
will be necessary. If the AKBR is less than 0.7 in a nondiabetic 
patient, the graft is hopeless. Even with AKBR l~Dels of 0.7 to 
1.0 in nondiabetic patients, the option of retransplantation 
should be considered seriously. Conversely, the achievement of 
an AKBR of 1.0 or better should discourage a decision for 
sPtClftClty 
GOT 
2nd Dlv 
GPT 
100% SIX'CtflClty 0% 
r-I---------------~I_I 
0% 
GOT and GPT with AKBR on the 2nd postoperative day; (lower left) 
Comparison between PT and AKBR on the 1st postoperative day; 
(lower right) Comparison between PT and AKBR on the 2nd postop-
erative day. 
retransplantation in spite of anxiety for other reasons about 
graft viability. 
Unfortunately, the road map is not so clear in patients who 
are temporarily or chronically diabetic, and in whom a reduced 
AKBR does not have the same prognostic significance. In this 
population, most of the AKBR levels were suboptimal, but this 
was not a uniformly ominous finding. 
It is known that the mitochondrial response to hepatectomy 
is suppressed in diabetic rats and that insulin is regarded as 
the primary factor governing the changes in the mitochondrial 
metabolism (16-18). It also has been shown the liver mito-
chondria are oxidized (the AKBR is increased) concomitant 
with a rise in serum insulin levels (19). Finally, apart from a 
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on the 2nd postoperative day; (lower, Comparison -between lactate at the end of operation and AKBR on the 1st postoperative 2y, 
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FIGURE 11. Changes in the AKBR after primary and secondary 
grafting. Values are presented as means ± SEM. (0) primary; (.) 
secondary. (0) and (00); P<0.05 and P<O.Ol, respectively. (AHP) an-
hepatic period. 
specific effect on the mitochondria, insulin has I proven influ-
ence on other measures of hepatocyte structure. :'mction, and 
the capacity for regeneration and repair (20, 2] '. These effects 
have been termed Whepatotrophic." Although f.:.her investi-
gations are needed. it is already clear that insu:':': administra-
tion via an adequate route in "diabetic" patier::l could be of 
the utmost importance in postoperative man~"D!:nentK Other 
supponive care should include parenteral nutri:;,."tl. including 
provision of suitable energy substitutes. 
After the immediate postoperative period, acute rejection has 
been shown in rats to decrease the redox poten:=aI of hepatic 
mitochondria (22). The same thing was seen d:'Clatically in 
one of our recipients whose rejecting liver was ltSCUed with 
FK506. The patient who was unconscious with npidly devel-
oping hyperbilirubinemia and declining AKBR hid reversal of 
all these parameters within a short time after substituting 
FK506 for cyclosporine. 
Recent studies in Pittsburgh have demonstrateci I correlation 
of high endotoxin levels pre- and postoperati\'ely and during 
the an hepatic period with graft failure and a ~ mortality 
(23, 24). Related studies in Kyoto have shoWl: that severe 
endotoxemia typically occurs after the decrease is the AKBR 
in patients undergoing partial hepatectomy (25). :\ decrease in 
the AKBR may be the basic cause leading to mdtiple organ 
failure (3. 4). A marked decreased in the AKBR ro:ld be a case 
of endotoxemia and graft failure, or alternatively rouId be the 
consequence of endotoxemia. The interaction of ~ factors 
will be important to clarify in future research. 
t 
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ORAL DISCUSSION 
DR. BUSUTTIL (Los Angeles, California); As you know, we 
are looking at KBR at UCLA, and our results with adults are 
very similar to what you have shown. However, in a group of 
children which we have studied, we found that they are much 
more forgiving. They can have a lower KBR for a longer period 
of time and still show evidence of very nice graft function. Do 
yOU have an explanation for that? 
DR. ASONUMA: I have no data for the children, so I can't 
say anything, but there might be some difference between the 
children and adults. In adults we think the State 3 KBR at 24 
hr or at 48 hr is very critical. 
DR. GORDON (Pittsburgh, Pennsylvania); Have you studied 
at all patients who are taking FK with the KBR? FK has 
interesting effects on the liver that far exceed those of cyclo-
sporine, such as the hepatotrophic effect. Is there any difference 
in these ratios in patients taking FK versus cyclosporine? 
DR. ASONUMA: Both of these patients are FK patients and 
you can see the results. The graft failure is less than the 
previous reports of the cyclosporine. We tried to compare the 
cyclosporine patients and the FK patients in the changes of 
the AKBR, but we cannot find that here in this study. 
DR. BOLLINGER (Duke University): Can I ask, Dr. Ason-
uma, how you are using this indicator at Pittsburgh right now? 
DR. ASONUMA: We're trying to do a preliminary study to 
the routine examination, but the system is not yet established. 
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